A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents
收藏DataCite Commons2024-07-06 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009265/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this multi-center event-driven study in participants with anemia associated
with chronic kidney disease (CKD) to evaluate the safety and efficacy of daprodustat.
提供机构：
Vivli
创建时间：
2023-09-12
